Danaher Ventures, the venture arm of the life sciences giant Danaher, is investing $18 million into a startup co-founded by Carl June that aims to make cheaper, faster cell therapies.

生命科学巨头Danaher的风险部门Danaher Ventures正在投资1800万美元，由Carl June共同创立的一家初创企业，旨在制造更便宜，更快的细胞疗法。

Novalis LifeSciences and Marshall Wace also participated in the seed round for BlueWhale Bio, which comes out of the University of Pennsylvania.

Novalis LifeSciences和Marshall Wace也参加了来自宾夕法尼亚大学的BlueWhale Bio种子轮。

June, whose research led to the development of CAR-T cell therapy to treat cancer, and Penn professor James Riley are co-inventors of the technology that is the basis of BlueWhale’s platform. June is also a member of Danaher’s scientific advisory board.

June的研究导致了用于治疗癌症的CAR-T细胞疗法的发展，Penn教授James Riley是BlueWhale平台基础技术的共同发明者。六月也是Danaher科学顾问委员会的成员。

Unlock this article instantly by becoming a free subscriber.

成为免费用户立即解锁本文。

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

您可以每月访问免费文章，还可以自定义每周发送到框中的新闻通讯，包括新闻报道。

SIGN UP

注册

LOG IN

登录

BECOME A PREMIUM SUBSCRIBER

成为高级用户